This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (79)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Drug Therapy, Other  • Statistics and Research Methods  • Conflict of Interest  • Medical Ethics  • Randomized Controlled Trial  • Alert me on articles by topic

Karine Morin, LLM; Herbert Rakatansky, MD; Frank A. Riddick, Jr, MD; Leonard J. Morse, MD; John M. O'Bannon III, MD; Michael S. Goldrich, MD; Priscilla Ray, MD; Matthew Weiss, MD; Robert M. Sade, MD; Monique A. Spillman, MD,PhD

JAMA. 2002;287:78-84.

The interaction between medical research and for-profit corporations is not new, but it has expanded considerably in recent years. Some of the recent trends may accelerate the research process, particularly when large clinical trials are required. However, a renewed commitment to the application of high ethical standards is essential to ensure that societal trust in research is not eroded, subjects enrolled in trials do not become merely a means to an end, and medical research is efficiently translated into clinical advances that will benefit future patients. This article focuses on the analysis of conflicts of interest in the conduct of clinical trials in both academic and community-based settings. Specifically, it discusses how the roles of research scientists and clinical practitioners differ and the importance of ensuring that participants' consent to enroll in clinical trials is not the result of confusion about the goals of an experimental treatment that may resemble clinical care. The article also discusses the potential conflicts of interest that can arise when clinicians stand to gain from enrolling their own patients as subjects in clinical trials and examines various instances in which disclosure of information regarding funding and compensation may serve to minimize such conflicts. This article emphasizes that to preserve the integrity of research and to protect the welfare of human subjects who enroll in trials, physicians should have adequate training in the conduct of research and be familiar with the ethics of research. When a physician has treated or continues to treat a patient who is eligible to enroll as a subject in a clinical trial conducted by the same physician, someone other than the treating physician should obtain the participant's informed consent. Finally, the article addresses disclosure of financial incentives and related funding issues.

Author Affiliations: Council on Ethical and Judicial Affairs, American Medical Association, Chicago, Ill.

RELATED ARTICLES

January 2, 2002
JAMA. 2002;287(1):129-130.
EXTRACT | FULL TEXT  

Medical Innovation and Institutional Interdependence: Rethinking University-Industry Connections
Annetine C. Gelijns and Samuel O. Thier
JAMA. 2002;287(1):72-77.
ABSTRACT | FULL TEXT  

Legal Issues in Scientific Research
Paul E. Kalb and Kristin Graham Koehler
JAMA. 2002;287(1):85-91.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Attitudes Toward Research Participation and Investigator Conflicts of Interest Among Advanced Cancer Patients Participating in Early Phase Clinical Trials
Gray et al.
JCO 2007;25:3488-3494.
ABSTRACT | FULL TEXT  

Lessons Learned From the Children's Environmental Exposure Research Study
Resnik and Wing
Am. J. Public Health 2007;97:414-418.
ABSTRACT | FULL TEXT  

Informed Trust and the Financing of Biomedical Research
Sharp and Yarborough
J Law Med Ethics 2006;34:460-464.
 

Financial Relationships with Industry and Device Research Involving Non-Food and Drug Administration-approved Use: A Perspective.
Becker
Radiology 2006;239:626-628.
FULL TEXT  

Financial Conflicts of Interest in Physicians' Relationships with the Pharmaceutical Industry -- Self-Regulation in the Shadow of Federal Prosecution
Studdert et al.
NEJM 2004;351:1891-1900.
FULL TEXT  

Task Force 1: The ACCF and AHA codes of conduct in human subjects research
Alpert et al.
J Am Coll Cardiol 2004;44:1724-1728.
FULL TEXT  

Task force 3: Disclosure of relationships with commercial interests: Policy for educational activities and publications
Jacobs et al.
J Am Coll Cardiol 2004;44:1736-1740.
FULL TEXT  

Task Force 1: The ACCF and AHA Codes of Conduct in Human Subjects Research
Alpert et al.
Circulation 2004;110:2512-2516.
FULL TEXT  

Task Force 3: Disclosure of Relationships With Commercial Interests: Policy for Educational Activities and Publications
Jacobs et al.
Circulation 2004;110:2524-2528.
FULL TEXT  

Litigation in Clinical Research: Malpractice Doctrines Versus Research Realities
Morreim
J Law Med Ethics 2004;32:474-484.
 

Currents in Contemporary Ethics
Caulfield et al.
J Law Med Ethics 2004;32:365-368.
 

The Clinician as Investigator: Participating in Clinical Trials in the Practice Setting
Lader et al.
Circulation 2004;109:2672-2679.
ABSTRACT | FULL TEXT  

Industry Sponsorship and Authorship of Clinical Trials Over 20 Years
Buchkowsky and Jewesson
The Annals of Pharmacotherapy 2004;38:579-585.
ABSTRACT | FULL TEXT  

Conflicts of Interest in Biomedical Research Harm Children With and Without Disabilities
Sharav
Journal of Disability Policy Studies 2004;15:50-59.
ABSTRACT  

Reforming clinical research and development in England
McNally et al.
BMJ 2003;327:550-553.
FULL TEXT  

United Kingdom research governance strategy
Kerrison et al.
BMJ 2003;327:553-556.
FULL TEXT  

Research-Related Injury: Problems and Solutions
Scott
J Law Med Ethics 2003;31:419-428.
 

Industry-Sponsored Economic Studies in Critical and Intensive Care Versus Studies Sponsored by Nonprofit Organizations
Hartmann et al.
J Intensive Care Med 2003;18:265-268.
ABSTRACT  

The power of clinical trials and guidelines,and the challenge of conflicts of interest
Bruce Fye
J Am Coll Cardiol 2003;41:1237-1242.
FULL TEXT  

Clinical Research and the Physician-Patient Relationship
Chen et al.
ANN INTERN MED 2003;138:669-672.
ABSTRACT | FULL TEXT  

Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
Bekelman et al.
JAMA 2003;289:454-465.
ABSTRACT | FULL TEXT  

Nonfinancial Conflicts of Interest in Research
Sollitto et al.
NEJM 2002;347:2173-2173.
FULL TEXT